Cellectis to Report Third Quarter Financial Results on November 12, 2026
Filed with Euronext · · 1 page · English
Story so far
Earlier from Cellectis
- Monthly information on share capital and company voting rights
- Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with.HEAL-101 at ESGCT 2026
- Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company
- Cellectis annonce sa transformation stratégique en société d'édition du génome in vivo
- Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update
Later from Cellectis
All Cellectis news releasesFollow Cellectis into a list and get an email when it puts out news.
Follow Cellectis